C. Frank Bennett, EVP, Chief Scientific Officer at IONIS PHARMACEUTICALS INC (IONS), sold 85,709 shares at $49.14 ($5.1M) on 2025-09-02, disclosed to the SEC on 2025-09-04.
Scheduled sale ($5.1M) by EVP, Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.14 | 5,000 | $246K | 4.8% |
| 2 | $60.62 | 33,909 | $2.1M | 39.9% |
| 3 | $60.62 | 33,909 | $2.1M | 39.9% |
| 4 | $61.50 | 12,891 | $793K | 15.4% |
| Total | $60.08 avg | 85,709 | $5.1M | 100% |
| Filing → |
| IONS | SELL | 2026-02-04 | $14.1M | — | Filing → |
| IONS | SELL | 2026-02-02 | $976K | — | Filing → |
| IONS | SELL | 2026-01-20 | $675K | — | Filing → |